| MERSANA THERAPEUTICS |
| USA |
| Gesundheit |
| US59045L2051 / A41BV2 |
| 0M40 (Frankfurt) / MRSN (NASDAQ) |
| FRA:0M40, ETR:0M40, 0M40:GR, NASDAQ:MRSN |
| - |
| https://www.mersana.com/ |
|
Mersana Therapeutics, Inc. is a clinical-stage bio..
>Volltext.. |
| 124.21 Mio. EUR |
| 77.66 Mio. EUR |
| 28.33 Mio. EUR |
| -56.58 Mio. EUR |
| -59.84 Mio. EUR |
| -12.03 EUR |
| 1.96 Mio. EUR |
| 48.56 Mio. EUR |
| -63.5 Mio. EUR |
| 1.31 |
| -9.63% |
| 10.89% |
| - |
| - |
| - |
| - |
| MERSANA |
| 20.12.25 |
|
||||
|
||||
|